Literature DB >> 15638042

The effect of taurine chloramine on pro-inflammatory cytokine production by peripheral blood mononuclear cells isolated from rheumatoid arthritis and osteoarthritis patients.

M Chorazy-Massalska1, E Kontny, A Kornatka, M Rell-Bakalarska, J Marcinkiewicz, W Maśliński.   

Abstract

OBJECTIVE: Pro-inflammatory cytokines play a critical role in the pathogenesis of RA. A natural oxidant, TauCl exerts anti-inflammatory activities. Here, the effects of Tau and TauCl on key pro-inflammatory cytokines--IL-1beta, IL-6 and TNF-alpha production by LPS-triggered peripheral blood mononuclear cells (PBMCs) isolated from RA and OA patients and healthy blood donors--were examined.
METHODS: PBMCs were stimulated with LPS (24 h) in the presence of Tau or TauCl (200-400 microM). Cytokine production was measured in culture supernatants (secreted) and cells lysates (cell-associated) using specific ELISAs.
RESULTS: Production of the secretedforms of IL-1beta and IL-6 was inhibited by TauCl with IC50 approximately equal to 250 microM and 300-400 microM respectively, in all investigated groups. In all cultures of PBMCs TauCl raised the TNF-alpha production at the low concentration (200 mM), while at the higher concentration (400 microM) either reduced it (55% of RA, 70% of OA patients and 55% of healthy donors) or exerted no effect (remainder of patients). Interestingly, Tau did not significantly affect any cytokine production.
CONCLUSION: TauCl at high concentrations down-regulates pro-inflammatory cytokine production. However, the impact of TauCl on TNF-alpha production by PBMCs from RA is more limited than in cells isolated from OA patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638042

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality.

Authors:  K Lorenz; D Mayer; G Bruhn; B Noack; M Brecx; C Heumann; H Toutenburg; L Netuschil; M Nagl; W Gottardi; T Hoffmann
Journal:  Clin Oral Investig       Date:  2008-06-27       Impact factor: 3.573

Review 2.  Taurine and inflammatory diseases.

Authors:  Janusz Marcinkiewicz; Ewa Kontny
Journal:  Amino Acids       Date:  2012-07-19       Impact factor: 3.520

3.  The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.

Authors:  Neveen Madbouly; Ayman Azmy; Abeer Salama; Azza El-Amir
Journal:  J Antibiot (Tokyo)       Date:  2021-07-12       Impact factor: 2.649

4.  A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis.

Authors:  Aida Malek Mahdavi; Zeinab Javadivala
Journal:  Amino Acids       Date:  2021-04-30       Impact factor: 3.520

Review 5.  Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.

Authors:  Md Jakaria; Shofiul Azam; Md Ezazul Haque; Song-Hee Jo; Md Sahab Uddin; In-Su Kim; Dong-Kug Choi
Journal:  Redox Biol       Date:  2019-05-21       Impact factor: 11.799

6.  Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis.

Authors:  Dawei Cai; Shasha Yin; Jun Yang; Qing Jiang; Wangsen Cao
Journal:  Arthritis Res Ther       Date:  2015-09-26       Impact factor: 5.156

Review 7.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

Review 8.  The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.

Authors:  Tawar Qaradakhi; Laura Kate Gadanec; Kristen Renee McSweeney; Jemma Rose Abraham; Vasso Apostolopoulos; Anthony Zulli
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.